India's Most Influential Business and Economy Magazine - A Planman Media Initiative 
  Other Sections
  • Home
  •  Cover Story
  •  B&E This Fortnight
  •  B&E Indicators
  • BE Corporation
  • Finance
  • International Column
  • National Story
  • Policy
  • Scrutiny
  • Sector
  • Snapshot
  • Testimonial
Making sense of the incorrigibly Cognizant!
Cognizant’s ability to consistently achieve astronomical revenue growth has surprised many. Will it’s new strategic outlook be able to keep the ‘shock & awe’ coming?
While debating on a particular strategy related to employee & customer orientation in a technology company with a top CEO, I gave the logic that works best when you are trying to escape an argument – ....Read More

Ranbaxy’s cookie – will it crumble?
Much of Ranbaxy’s fortunes is riding on the way its impasse with the USFDA over Lipitor generic sales pans out. The timely resolution of the dispute can make a big difference for India’s largest drugmaker – between making a fortune and being content with making a living. Caution: November is fast-approaching.
The feelings run both ways. Indian generic drugmakers exporting to US are salivating over a goldmine of opportunity worth $96 billion that is expected to come their way from drugs going off-patent bet....Read More

Busines & Economy is also associated with :
©Copyright 2008, Planman Media Pvt. Ltd. An Arindam Chaudhuri Initiative. With Intellectual Support from IIPM & Malay Chaudhuri.